Abbott Laboratories (ABT)

ABT (NYSE:Health Services)
$42.97
neg -0.12
-0.28%
Today's Range: 42.87 - 43.27 | ABT Avg Daily Volume: 5,308,400
Last Update: 07/23/14 - 4:01 PM EDT
Volume: 4,315,170
YTD Performance: 12.42%
Open: $43.25
Previous Close: $43.09
52 Week Range: $32.70 - $43.23
Oustanding Shares: 1,501,938,538
Market Cap: 61,654,576,985
6-Month Chart
TheStreet Ratings Grade for ABT
Buy Hold Sell
A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F
TheStreet Ratings is the source for accurate ratings that you can rely upon to make sound, informed financial decisions. Click here to find out about our methodology.
Analysts Ratings
Historical Rec Current 1 Mo. Ago 2 Mo. Ago 3 Mo. Ago
Strong Buy 7 8 8 8
Moderate Buy 3 3 2 2
Hold 6 6 7 7
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 1.91 1.85 1.91 1.91
Latest Dividend: 0.22
Latest Dividend Yield: 2.05%
Dividend Ex-Date: 07/11/14
Price Earnings Ratio: 27.36
Price Earnings Comparisons:
ABT Sector Avg. S&P 500
27.36 27.00 28.87
Price Performance History (%Change):
3 Mo 1 Yr 3 Y
11.63% 20.36% 62.76%
GROWTH 12 Mo 3 Yr CAGR
Revenue -45.20 -0.38 -0.15
Net Income -56.80 -0.48 -0.20
EPS -56.80 -0.45 -0.18
Earnings for ABT:
EBITDA 4.35B
Revenue 21.85B
Average Earnings Estimates
Qtr (09/14) Qtr (12/14) FY (12/14) FY (12/15)
Average Estimate $0.61 $0.69 $2.22 $2.48
Number of Analysts 11 11 13 16
High Estimate $0.63 $0.73 $2.25 $2.87
Low Estimate $0.56 $0.66 $2.19 $2.30
Prior Year $0.55 $0.58 $2.01 $2.22
Growth Rate (Year over Year) 10.08% 19.28% 10.37% 11.90%
Chart Benchmark Timeframe
Average Frequency Indicator Chart
Scale Symbol Comparison Bollinger Bands
Bearish
Jul 21, 2014 | 7:59 AM EDT
ABT 2015E-2018E EPS estimates lowered 7-10%, Jefferies said. Buy rating. Estimates reflect the divestiture of the developed market EPD ...

This Morning's Market Setup Real Money Pro($)

Where it began.
Bullish
May 19, 2014 | 8:18 AM EDT
ABT was upgraded from Neutral to Outperform, Credit Suisse said. $46 price target. Company is more attractive, following the CFR acquis...
Update
May 08, 2014 | 7:08 AM EDT
Deutsche Bank Healthcare Conference
Bullish
Mar 19, 2014 | 7:29 AM EDT
ABT lowered its number, Jefferies said. Pricing pressure in EPD, MD pricing/volume pressurse and FX exposure. $45 price target. Buy rat...
Update
Feb 12, 2014 | 8:02 AM EST
Shares of ABT dropped to $46, according to Jefferies. Pricing pressure in EPS and FX exposure. Buy rating. 
Great investors and great quarterbacks have a lot in common.

Healthcare Holding Strong Real Money Pro($)

It's clear that bulls in this sector aren't weak hands.

Abbott Labs Breaks Out Real Money Pro($)

Bullish action has set the stock up well for more upside.
U.S. futures are positive to start first full week of 2014 trading.

Columnist Conversations

The semiconductor sector performed poorly today with the Market Vectors Semiconductor (SMH) fund down over 2% ...
Is this the biotech revolution or the biotech bust? View Small Cap Biotechs Like Never Before: Transparency is...
ive tried to sense how these new rules can possibly be good for the mkt--and struck out trying. the investmen...
Skip Raschke and I have been talking about THIS behind the scenes. Note the following excerpt: "The rules also...

REAL MONEY'S BEST IDEAS

Columnist Tweets

BROKERAGE PARTNERS

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.


TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.